NKGen Biotech, Inc. (NKGN)
0.011
0.00 (0.00%)
USD |
OTCM |
Nov 06, 16:00
NKGen Biotech Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2025 | -50.15M |
| December 31, 2024 | -69.73M |
| September 30, 2024 | -46.80M |
| June 30, 2024 | -59.01M |
| March 31, 2024 | -44.67M |
| December 31, 2023 | -40.40M |
| September 30, 2023 | -7.723M |
| June 30, 2023 | 54.26M |
| March 31, 2023 | 169.38M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.563M |
| September 30, 2022 | 168.29M |
| June 30, 2022 | 167.40M |
| March 31, 2022 | 162.72M |
| December 31, 2021 | 160.72M |
| September 30, 2021 | 162.06M |
| June 30, 2021 | 157.37M |
| March 31, 2021 | -0.0107M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 613.09M |
| C4 Therapeutics, Inc. | 228.17M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |